loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Olaparib.

Menu
$ API Ref.Price (USD/KG) : 7,761Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
BioJapan 2024
Not Confirmed
arrow
BioJapan 2024
Not Confirmed

Olaparib

Brand Name : LYNPARZA

Patent Number : 2547077

Filing Date : 2004-11-30

Strength per Unit : 50 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-11-30

Date Granted : 2015-11-03

blank

02

arrow
BioJapan 2024
Not Confirmed
arrow
BioJapan 2024
Not Confirmed

Olaparib

Brand Name : LYNPARZA

Patent Number : 2664275

Filing Date : 2007-10-15

Strength per Unit : 50 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-10-15

Date Granted : 2015-03-17

blank

03

arrow
BioJapan 2024
Not Confirmed
arrow
BioJapan 2024
Not Confirmed

Olaparib

Brand Name : LYNPARZA

Patent Number : 2423279

Filing Date : 2001-10-25

Strength per Unit : 50 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-10-25

Date Granted : 2011-07-05

blank

04

arrow
BioJapan 2024
Not Confirmed
arrow
BioJapan 2024
Not Confirmed

Olaparib

Brand Name : LYNPARZA

Patent Number : 2517629

Filing Date : 2004-03-12

Strength per Unit : 50 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-03-12

Date Granted : 2011-07-12

blank